These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1141715)

  • 21. Postural skin colour changes during the corticosteroid blanching assay.
    Henry F; Fumal I; Piérard GE
    Skin Pharmacol Appl Skin Physiol; 1999; 12(4):199-210. PubMed ID: 10420140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
    Wiedersberg S; Naik A; Leopold CS; Guy RH
    Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
    Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glucocorticosteroids on epidermal Langerhans cells.
    Belsito DV; Flotte TJ; Lim HW; Baer RL; Thorbecke GJ; Gigli I
    J Exp Med; 1982 Jan; 155(1):291-302. PubMed ID: 6459400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy of topical corticosteroids.
    Zaynoun ST; Kurban AK
    Br J Dermatol; 1974 Jan; 90(1):85-90. PubMed ID: 4811838
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on topical antiinflammatory agents. I. Synthesis and vasoconstrictive activity of corticosteroid 17-succinyl esters.
    Mitsukuchi M; Nakagami J; Ikemoto T; Higuchi S; Tarumoto Y; Yasui H; Sota K
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1534-9. PubMed ID: 2776236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RU 486 inhibits peripheral effects of glucocorticoids in humans.
    Gaillard RC; Poffet D; Riondel AM; Saurat JH
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1009-11. PubMed ID: 4055982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Animal experiment studies on the local activity of 9-alpha-fluoro-16-alpha-methyl-17-desoxy-prednisolone].
    Schröder HG; Babej M; Vogel HG
    Arzneimittelforschung; 1974 Jan; 24(1):3-5. PubMed ID: 4406107
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of corticosteroids intended for use as topical anti-inflammatory drugs.
    Bagatell FK; Augustine MA
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):748-57. PubMed ID: 4210465
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
    Täuber VU; Amin M; Fuchs P; Speck U
    Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
    Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids.
    Noon JP; Evans CE; Haynes WG; Webb DJ; Walker BR
    Br J Dermatol; 1996 May; 134(5):837-42. PubMed ID: 8736322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biotransformation of diflucortolone valerate in the skin of rat, guinea pig and man (author's transl)].
    Täuber VU; Toda T
    Arzneimittelforschung; 1976; 26(7b):1484-7. PubMed ID: 1036940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.